These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 6121922)
1. [Somatostatin and its action mechanism]. Kokubu T; Sawano S Nihon Rinsho; 1981 Sep; 39(9):2933-7. PubMed ID: 6121922 [No Abstract] [Full Text] [Related]
2. Comparative studies with cyclic and linear somatostatin on active avoidance behaviour and open-field activity in rats. Vécsei L; Bollók I; Telegdy G Acta Physiol Hung; 1983; 61(1-2):43-9. PubMed ID: 6138920 [TBL] [Abstract][Full Text] [Related]
4. The radioimmunoassay and physiology of somatostatin in the pancreas and gastrointestinal tract. McIntosh C; Arnold R Z Gastroenterol; 1978 May; 16(5):330-40. PubMed ID: 349906 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057 [TBL] [Abstract][Full Text] [Related]
7. Extended retro-inverso analogs of somatostatin. Pallai P; Struthers S; Goodman M; Rivier J; Vale W Biopolymers; 1983 Dec; 22(12):2523-38. PubMed ID: 6141815 [No Abstract] [Full Text] [Related]
8. Common structural features for cytoprotection activities of somatostatin, antamanide and related peptides. Kessler H; Gehrke M; Haupt A; Klein M; Müller A; Wagner K Klin Wochenschr; 1986; 64 Suppl 7():74-8. PubMed ID: 2882054 [No Abstract] [Full Text] [Related]
9. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. Murphy WA; Taylor JE; Moreau JP; Coy DH Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697 [TBL] [Abstract][Full Text] [Related]
10. [The development of a radioimmunoassay for somatostatin using 125I-(Tyr8)-somatostatin as a labelled antigen (author's transl)]. Kokubu T; Sawano S; Ohashi S Nihon Naibunpi Gakkai Zasshi; 1980; 56(12):1630-48. PubMed ID: 6110569 [No Abstract] [Full Text] [Related]
12. Backbone modifications in somatostatin analogues: relation between conformation and activity. Van Binst G; Tourwé D Pept Res; 1992; 5(1):8-13. PubMed ID: 1352471 [TBL] [Abstract][Full Text] [Related]
13. Development of a sensitive somatostatin radioimmunoassay and its application to plasma of stressed and non-stressed rats. Engelhardt W; Schwille PO Horm Metab Res; 1981 Jun; 13(6):318-23. PubMed ID: 6114917 [TBL] [Abstract][Full Text] [Related]
14. [Action mechanism of somatostatin]. Kaneko T Nihon Rinsho; 1976 Dec; 34(12):3479-83. PubMed ID: 1035288 [No Abstract] [Full Text] [Related]
16. [Somatostatin and its receptors. Role in the control of cell proliferation]. Florio T; Schettini G Minerva Endocrinol; 2001 Sep; 26(3):91-102. PubMed ID: 11753230 [TBL] [Abstract][Full Text] [Related]
19. [Radioimmunoassay of somatostatin and its degradation in the serum]. Kokubu T; Ohashi S; Sawano S; Kobayashi T; Takeda S Horumon To Rinsho; 1978 Jun; 26(6):552-4. PubMed ID: 688656 [No Abstract] [Full Text] [Related]
20. [Somatostatin--chemical structure, function and clinical use]. Sawano S; Oohashi S Nihon Rinsho; 1976; 34(3):620-6. PubMed ID: 819680 [No Abstract] [Full Text] [Related] [Next] [New Search]